Daxor Corporation
Daxor Corporation Fundamental Analysis
Daxor Corporation (DXR) shows weak financial fundamentals with a PE ratio of 34.00, profit margin of 2.52%, and ROE of 5.03%. The company generates $0.0B in annual revenue with strong year-over-year growth of 12.04%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 52.0/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze DXR's fundamental strength across five key dimensions:
Efficiency Score
WeakDXR struggles to generate sufficient returns from assets.
Valuation Score
ModerateDXR shows balanced valuation metrics.
Growth Score
ExcellentDXR delivers strong and consistent growth momentum.
Financial Health Score
ModerateDXR shows balanced financial health with some risks.
Profitability Score
WeakDXR struggles to sustain strong margins.
Key Financial Metrics
Is DXR Expensive or Cheap?
P/E Ratio
DXR trades at 34.00 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, DXR's PEG of 0.13 indicates potential undervaluation.
Price to Book
The market values Daxor Corporation at 1.72 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 18.41 times EBITDA. This signals the market has high growth expectations.
How Well Does DXR Make Money?
Net Profit Margin
For every $100 in sales, Daxor Corporation keeps $2.52 as profit after all expenses.
Operating Margin
Core operations generate 2.71 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $5.03 in profit for every $100 of shareholder equity.
ROA
Daxor Corporation generates $5.01 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Daxor Corporation generates limited operating cash flow of $-35.39K, signaling weaker underlying cash strength.
Free Cash Flow
Daxor Corporation generates weak or negative free cash flow of $-35.39K, restricting financial flexibility.
FCF Per Share
Each share generates $-0.01 in free cash annually.
FCF Yield
DXR converts -0.06% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
34.00
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.13
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.72
vs 25 benchmark
P/S Ratio
Price to sales ratio
86.56
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.007
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.00
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.05
vs 25 benchmark
ROA
Return on assets percentage
0.05
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How DXR Stacks Against Its Sector Peers
| Metric | DXR Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 34.00 | 29.43 | Worse (Expensive) |
| ROE | 5.03% | 800.00% | Weak |
| Net Margin | 251.87% | -20145.00% (disorted) | Strong |
| Debt/Equity | 0.01 | 0.30 | Strong (Low Leverage) |
| Current Ratio | 0.00 | 4.64 | Weak Liquidity |
| ROA | 5.01% | -17936.00% (disorted) | Weak |
DXR outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Daxor Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
1702.10%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
193.54%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
-99.29%
Industry Style: Defensive, Growth, Innovation
Declining